Variant report
Variant | nsv962130 |
---|---|
Chromosome Location | chr2:52588159-52598836 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:17)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:17 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr2:52594040-52594190 | GM12869 | blood: | n/a | n/a |
2 | EP300 | chr2:52596370-52596765 | T-47D | breast: | n/a | n/a |
3 | FOXA1 | chr2:52596298-52596674 | T-47D | breast: | n/a | n/a |
4 | FOXA1 | chr2:52596382-52596643 | T-47D | breast: | n/a | n/a |
5 | GATA3 | chr2:52596389-52596627 | T-47D | breast: | n/a | n/a |
6 | GATA3 | chr2:52596387-52596681 | T-47D | breast: | n/a | n/a |
7 | GATA3 | chr2:52595386-52595610 | T-47D | breast: | n/a | n/a |
8 | HDAC2 | chr2:52596356-52596719 | MCF-7 | breast: | n/a | n/a |
9 | POLR2A | chr2:52592176-52592253 | GM12878 | blood: | n/a | n/a |
10 | POLR2A | chr2:52595671-52595829 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | POLR2A | chr2:52597599-52597672 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | SETDB1 | chr2:52590883-52591191 | U2OS | brain: | n/a | n/a |
13 | SIN3AK20 | chr2:52596288-52596768 | MCF-7 | breast: | n/a | n/a |
14 | STAT3 | chr2:52597336-52597514 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | ZNF143 | chr2:52591010-52591161 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | ZNF143 | chr2:52597455-52597507 | GM12878 | blood: | n/a | n/a |
17 | ZNF217 | chr2:52596436-52596615 | MCF-7 | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000225444 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs116542899 | chr2:52588180-52588181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs138748019 | chr2:52588190-52588191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs148928457 | chr2:52588195-52588196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534723516 | chr2:52588237-52588238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs143631887 | chr2:52588243-52588244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs6706839 | chr2:52588260-52588261 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs190530522 | chr2:52588269-52588270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs148116119 | chr2:52588288-52588289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs17042808 | chr2:52588289-52588290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs13432341 | chr2:52588340-52588341 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs540129767 | chr2:52588349-52588350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141875006 | chr2:52588353-52588354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572049230 | chr2:52588368-52588369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs531760846 | chr2:52588408-52588409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs2955290 | chr2:52588411-52588412 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs574402824 | chr2:52588417-52588418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs2955289 | chr2:52588483-52588484 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs13432527 | chr2:52588506-52588507 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs532218824 | chr2:52588517-52588518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs552029315 | chr2:52588527-52588528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs2969313 | chr2:52588534-52588535 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs4971809 | chr2:52588622-52588623 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs139220199 | chr2:52588673-52588674 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568447737 | chr2:52588685-52588686 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs187082732 | chr2:52588686-52588687 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189567949 | chr2:52588687-52588688 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115688277 | chr2:52588739-52588740 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143349879 | chr2:52588774-52588775 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs13012563 | chr2:52588775-52588776 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs182497320 | chr2:52588822-52588823 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs147533615 | chr2:52588848-52588849 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs369111710 | chr2:52588873-52588874 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs536158146 | chr2:52588922-52588923 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs554226550 | chr2:52588947-52588948 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574413425 | chr2:52588961-52588962 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs114975871 | chr2:52588970-52588971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs557045240 | chr2:52589005-52589006 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs576610866 | chr2:52589033-52589034 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs143626070 | chr2:52589062-52589063 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs569293804 | chr2:52589069-52589070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2262851 | chr2:52589138-52589139 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs372808469 | chr2:52589160-52589161 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs2356040 | chr2:52589185-52589186 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs528326240 | chr2:52589197-52589198 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs549931891 | chr2:52589199-52589200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs114167450 | chr2:52589203-52589204 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs188061757 | chr2:52589235-52589236 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs193087167 | chr2:52589240-52589241 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs570991995 | chr2:52589259-52589260 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs13398489 | chr2:52589282-52589283 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:52586600-52590600 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
2 | chr2:52587800-52591000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
3 | chr2:52588600-52589800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
4 | chr2:52589800-52592000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr2:52591000-52591600 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |
6 | chr2:52591200-52591400 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr2:52591400-52591600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr2:52591600-52591800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr2:52591600-52591800 | Strong transcription | HUES6 Cell Line | embryonic stem cell |
10 | chr2:52591800-52614800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
11 | chr2:52592000-52594200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
12 | chr2:52595400-52596000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
13 | chr2:52596400-52596600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |